RIPK3 and colitis: Therefore, additional work needs to do that excludes the possibility that HG-9-91-01 may bypass SIKs to inhibit RIPK3 kinase activity to functions in murine experimental colitis, melanin production, gluconeogenesis andβcell proliferation.